作者
Julia Ernst, Mareike Klinger-Strobel, Kathrin Arnold, Jana Thamm, Anita Hartung, Mathias W Pletz, Oliwia Makarewicz, Dagmar Fischer
发表日期
2018/10/1
期刊
European Journal of Pharmaceutics and Biopharmaceutics
卷号
131
页码范围
120-129
出版商
Elsevier
简介
Pulmonary infections with Pseudomonas aeruginosa and Burkholderia cepacia complex (Bcc) are difficult to treat and related with high mortality in some diseases like cystic fibrosis due to the recurrent formation of biofilms. The biofilm formation hinders efficient treatment with inhaled antibiotics due to a low penetration of the antibiotics through the polyanionic biofilm matrix and increased antimicrobial resistance of the biofilm-embedded bacteria. In this study, tobramycin (Tb) was encapsulated in particles based on poly(d,l,-lactide-co-glycolide) (PLGA) and poly(ethylene glycol)-co-poly(d,l,-lactide-co-glycolide) diblock (PEG-PLGA) to overcome the biofilm barrier with particle sizes of 225–231 nm (nanoparticles) and 896–902 nm (microparticles), spherical shape and negative zeta potentials. The effectiveness against biofilms of P. aeruginosa and B. cepacia was strongly enhanced by the encapsulation under fluidic …
引用总数
2018201920202021202220232024189811116